The PANGEA model: improving risk stratification in multiple myeloma
The PANGEA model: enhancing risk assessment for individuals with high-risk smoldering myelomaПодробнее
Genomic profiling of smoldering myeloma to improve risk stratification modelsПодробнее
Risk stratification in multiple myelomaПодробнее
The PANGEA model: a novel dynamic model used to define disease progression in multiple myelomaПодробнее
Improving risk stratification models for patients with MGUS and smoldering myelomaПодробнее
Risk stratification models for smoldering myelomaПодробнее
Using molecular abnormalities for risk stratification in multiple myeloma at the time of diagnosisПодробнее
Improving the risk stratification of patients with smoldering myelomaПодробнее
Redefining risk stratification in multiple myelomaПодробнее
An update on the PANGEA modelПодробнее
Risk stratification & treatment of multiple myeloma precursor conditionsПодробнее
Risk Stratification for MyelomaПодробнее
Utilizing AI for individualized treatment-adjusted risk stratification in newly diagnosed myelomaПодробнее
Rationale behind the development of the novel dynamic PANGEA modelПодробнее
The importance of improving precision when risk stratifying patients with multiple myelomaПодробнее
Risk Stratification for MGUS | Dr. S. Vincent Rajkumar | Oncology BrothersПодробнее
An update to the risk stratification of MGUS, SMM, and multiple myelomaПодробнее
Current and future approaches to risk stratification in multiple myeloma: using dynamic modelsПодробнее
Updated risk stratification model for smoldering multiple myelomaПодробнее
New risk stratification model for Multiple Myeloma. Mattia D'Agostino, University of Turin. #ash20Подробнее
